Oncolix Inc. (fka ONCX)

[DayDreeming]

Dream on Redman!!!!!! Keep hanging those carrots on the stick and sooner or later your stick can't support all of them....LOL

"Although osteosarcoma will be our first target for this drug, the preclinical data show CycloSamTM may be superior to Xifigo, a radiopharmaceutical marketed by Bayer ($464 million sales 2017) for the treatment of bone metastases. Our drug could also be a better choice for bone marrow ablation," stated Michael Redman, CEO of Oncolix. "Furthermore, if we enter into this license agreement, we will have a strengthened pipeline of drug candidates."